222 related articles for article (PubMed ID: 23063785)
1. The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids.
Wilson-Poe AR; Pocius E; Herschbach M; Morgan MM
Pharmacol Biochem Behav; 2013 Jan; 103(3):444-9. PubMed ID: 23063785
[TBL] [Abstract][Full Text] [Related]
2. Repeated cannabinoid injections into the rat periaqueductal gray enhance subsequent morphine antinociception.
Wilson AR; Maher L; Morgan MM
Neuropharmacology; 2008 Dec; 55(7):1219-25. PubMed ID: 18723035
[TBL] [Abstract][Full Text] [Related]
3. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
Smith PA; Selley DE; Sim-Selley LJ; Welch SP
Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
[TBL] [Abstract][Full Text] [Related]
4. Differential susceptibility of the PAG and RVM to tolerance to the antinociceptive effect of morphine in the rat.
Morgan MM; Clayton CC; Boyer-Quick JS
Pain; 2005 Jan; 113(1-2):91-8. PubMed ID: 15621368
[TBL] [Abstract][Full Text] [Related]
5. Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats.
Lane DA; Patel PA; Morgan MM
Neuroscience; 2005; 135(1):227-34. PubMed ID: 16084660
[TBL] [Abstract][Full Text] [Related]
6. Relative contribution of the dorsal raphe nucleus and ventrolateral periaqueductal gray to morphine antinociception and tolerance in the rat.
Campion KN; Saville KA; Morgan MM
Eur J Neurosci; 2016 Nov; 44(9):2667-2672. PubMed ID: 27564986
[TBL] [Abstract][Full Text] [Related]
7. Involvement of local cholecystokinin in the tolerance induced by morphine microinjections into the periaqueductal gray of rats.
Tortorici V; Nogueira L; Salas R; Vanegas H
Pain; 2003 Mar; 102(1-2):9-16. PubMed ID: 12620592
[TBL] [Abstract][Full Text] [Related]
8. Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey.
Wilson-Poe AR; Lau BK; Vaughan CW
Br J Pharmacol; 2015 Jan; 172(2):681-90. PubMed ID: 24916363
[TBL] [Abstract][Full Text] [Related]
9. Tolerance to repeated microinjection of morphine into the periaqueductal gray is associated with changes in the behavior of off- and on-cells in the rostral ventromedial medulla of rats.
Tortorici V; Morgan MM; Vanegas H
Pain; 2001 Jan; 89(2-3):237-44. PubMed ID: 11166480
[TBL] [Abstract][Full Text] [Related]
10. Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat.
Morgan MM; Bobeck EN; Ingram SL
Brain Res; 2009 Oct; 1295():59-66. PubMed ID: 19664608
[TBL] [Abstract][Full Text] [Related]
11. Chronic inflammatory pain prevents tolerance to the antinociceptive effect of morphine microinjected into the ventrolateral periaqueductal gray of the rat.
Mehalick ML; Ingram SL; Aicher SA; Morgan MM
J Pain; 2013 Dec; 14(12):1601-10. PubMed ID: 24161274
[TBL] [Abstract][Full Text] [Related]
12. Combined Treatment with Morphine and Δ9-Tetrahydrocannabinol in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal.
Gerak LR; France CP
J Pharmacol Exp Ther; 2016 May; 357(2):357-66. PubMed ID: 26937020
[TBL] [Abstract][Full Text] [Related]
13. Systemic morphine-induced release of serotonin in the rostroventral medulla is not mimicked by morphine microinjection into the periaqueductal gray.
Taylor BK; Basbaum AI
J Neurochem; 2003 Sep; 86(5):1129-41. PubMed ID: 12911621
[TBL] [Abstract][Full Text] [Related]
14. Topical cannabinoid enhances topical morphine antinociception.
Yesilyurt O; Dogrul A; Gul H; Seyrek M; Kusmez O; Ozkan Y; Yildiz O
Pain; 2003 Sep; 105(1-2):303-8. PubMed ID: 14499448
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla.
Suplita RL; Farthing JN; Gutierrez T; Hohmann AG
Neuropharmacology; 2005 Dec; 49(8):1201-9. PubMed ID: 16129456
[TBL] [Abstract][Full Text] [Related]
16. Changes in nociceptin/orphanin FQ levels in rat brain regions after acute and chronic cannabinoid treatment in conjunction with the development of antinociceptive tolerance.
Ulugol A; Topuz RD; Gunduz O; Kizilay G; Karadag HC
Fundam Clin Pharmacol; 2016 Dec; 30(6):537-548. PubMed ID: 27371029
[TBL] [Abstract][Full Text] [Related]
17. Non-opioid antinociception produced by brain stem injections of improgan: significance of local, but not cross-regional, cannabinoid mechanisms.
Hough LB; Svokos K; Nalwalk JW
Brain Res; 2009 Jan; 1247():62-70. PubMed ID: 18983834
[TBL] [Abstract][Full Text] [Related]
18. Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat.
de Novellis V; Mariani L; Palazzo E; Vita D; Marabese I; Scafuro M; Rossi F; Maione S
Neuroscience; 2005; 134(1):269-81. PubMed ID: 15953687
[TBL] [Abstract][Full Text] [Related]
19. Interactions between μ-opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration.
Maguire DR; Yang W; France CP
J Pharmacol Exp Ther; 2013 Jun; 345(3):354-62. PubMed ID: 23536317
[TBL] [Abstract][Full Text] [Related]
20. Microinjection of the vehicle dimethyl sulfoxide (DMSO) into the periaqueductal gray modulates morphine antinociception.
Fossum EN; Lisowski MJ; Macey TA; Ingram SL; Morgan MM
Brain Res; 2008 Apr; 1204():53-8. PubMed ID: 18342296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
